Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A case control study of AIDS related sclerosing cholangitis indicates that it has no overall influence on prognosis, but is responsible for a striking reversal of the usual inverse correlation of age and survival in HIV infection. Pain, the principal symptom, was controlled in surviving patients with analgesics alone. Twenty consecutive patients with AIDS related sclerosing cholangitis, defined from at least two characteristic lesions at endoscopic retrograde cholangiopancreatography, were followed for a minimum of 10 months or until death. Median age was 33.5 years (range 27-50). All had abdominal pain; 11 had diarrhoea. Alkaline phosphatase was > 2X normal in 13, but the bilirubin was raised in only three. The median CD4 was 0.024 x 10(9)/l (0.005-0.341). Thirteen had cryptosporidiosis, six had active cytomegalovirus, five had no gastrointestinal pathogen. Three patients are alive without AIDS related sclerosing cholangitis symptoms at 10, 11, and 21 months. Seventeen have died at median 7 (1-23) months. Cytomegalovirus therapy had no apparent influence. The initial CD4 was < 0.11 in all those dying within six months, but correlation of CD4 with prognosis was otherwise poor. Controls, matched for age, CD4, and opportunistic infections had virtually identical overall outcome (median survival 7.5 months) and the expected worse prognosis with increasing age. Increasing age, however, appeared protective in AIDS related sclerosing cholangitis (r = +0.6; p < 0.05): this is not explained by disproportionate degrees of immunosuppression, nor by opportunistic infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Cited by
Epidemiology and Clinical Features of Cryptosporidium Infection in Immunocompromised Patients
Hunter, P. R., & Nichols, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.145-154.2002 · Cited by 545
Bjoro, K., Froland, S. S., Yun, Z., Samdal, H. H., & Haaland, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412153312402 · Cited by 370
Sclerosing cholangitis: a focus on secondary causes
Abdalian, R., & Heathcote, J. E. (2006) · Hepatology · doi:10.1002/hep.21405 · Cited by 230
Wilschanski, M., Chait, P., Wade, J. A., Davis, L., Corey, M., Louis, P. S., Griffiths, A. M., Blendis, L. M., Moroz, S. P., Scully, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840220513 · Cited by 216
Human Cryptosporidiosis: Epidemiology, Transmission, Clinical Disease, Treatment, and Diagnosis
GRIFFITHS, J. (1998) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60117-7 · Cited by 190
Clinical Aspects of Human Cryptosporidiosis
Farthing, M. J. G. (2000) · Contributions to Microbiology · doi:10.1159/000060368 · Cited by 106
Secondary sclerosing cholangitis in critically ill patients: current perspectives
Gudnason, H. O., & Björnsson, E. S. (2017) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s115518 · Cited by 66
Will we ever model PSC? – “It's hard to be a PSC model!”
Pollheimer, M. J., Trauner, M., & Fickert, P. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.04.014 · Cited by 66
Nakanuma, Y., Zen, Y., & Portmann, B. C. (2012) · MacSween's Pathology of the Liver · doi:10.1016/b978-0-7020-3398-8.00010-6 · Cited by 56
Metadata
- Authors
- Forbes, A., Blanshard, C., & Gazzard, B.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1993-01
- Volume
- 34
- Issue
- 1
- Pages
- 116-121
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2110274975
- Cited by
- 130
- References
- 1
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.